Return On Equity of BioXcel Therapeutics, Inc. from 30 Sep 2018 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
BioXcel Therapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 30 Sep 2018 to 30 Sep 2025.
  • BioXcel Therapeutics, Inc. Return On Equity for the quarter ending 30 Sep 2025 was 72%, a 27% decline year-over-year.
  • BioXcel Therapeutics, Inc. annual Return On Equity for 2024 was 73%, a 96% decline from 2023.
  • BioXcel Therapeutics, Inc. annual Return On Equity for 2023 was 1873%.
  • BioXcel Therapeutics, Inc. annual Return On Equity for 2022 was -118%, a 154% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

BioXcel Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 72% -26% -27% 01 Jul 2025 30 Sep 2025
Q2 2025 54% -123% -69% 01 Apr 2025 30 Jun 2025
Q1 2025 47% -327% -88% 01 Jan 2025 31 Mar 2025
Q4 2024 73% -1799% -96% 01 Oct 2024 31 Dec 2024
Q3 2024 98% +989% 01 Jul 2024 30 Sep 2024
Q2 2024 177% +486% 01 Apr 2024 30 Jun 2024
Q1 2024 374% +552% 01 Jan 2024 31 Mar 2024
Q4 2023 1873% +1991% 01 Oct 2023 31 Dec 2023
Q3 2023 -891% -813% -1048% 01 Jul 2023 30 Sep 2023
Q2 2023 -309% -250% -422% 01 Apr 2023 30 Jun 2023
Q1 2023 -178% -129% -268% 01 Jan 2023 31 Mar 2023
Q4 2022 -118% -72% -154% 01 Oct 2022 31 Dec 2022
Q3 2022 -78% -33% -72% 01 Jul 2022 30 Sep 2022
Q2 2022 -59% -14% -31% 01 Apr 2022 30 Jun 2022
Q1 2022 -48% +7.8% +14% 01 Jan 2022 31 Mar 2022
Q4 2021 -46% +13% +22% 01 Oct 2021 31 Dec 2021
Q3 2021 -45% +29% +39% 01 Jul 2021 30 Sep 2021
Q2 2021 -45% +69% +60% 01 Apr 2021 30 Jun 2021
Q1 2021 -56% +46% +45% 01 Jan 2021 31 Mar 2021
Q4 2020 -59% +52% +47% 01 Oct 2020 31 Dec 2020
Q3 2020 -74% +23% +24% 01 Jul 2020 30 Sep 2020
Q2 2020 -115% -37% -47% 01 Apr 2020 30 Jun 2020
Q1 2020 -102% -49% -92% 01 Jan 2020 31 Mar 2020
Q4 2019 -111% -70% -169% 01 Oct 2019 31 Dec 2019
Q3 2019 -97% -57% -142% 01 Jul 2019 30 Sep 2019
Q2 2019 -78% 01 Apr 2019 30 Jun 2019
Q1 2019 -53% 01 Jan 2019 31 Mar 2019
Q4 2018 -41% 01 Oct 2018 31 Dec 2018
Q3 2018 -40% 01 Jul 2018 30 Sep 2018

BioXcel Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 73% -1799% -96% 01 Jan 2024 31 Dec 2024
2023 1873% +1991% 01 Jan 2023 31 Dec 2023
2022 -118% -72% -154% 01 Jan 2022 31 Dec 2022
2021 -46% +13% +22% 01 Jan 2021 31 Dec 2021
2020 -59% +52% +47% 01 Jan 2020 31 Dec 2020
2019 -111% -70% -169% 01 Jan 2019 31 Dec 2019
2018 -41% 01 Jan 2018 31 Dec 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.